Working Group

« » View all

Surveillance Workgroup (SRV-WG) Q4-2015 Update

The SRV-WG is defining the magnitude and trends of drug resistance in high burden countries, with particular focus on new and existing drugs for which resistance surveillance data are largely unavailable. Furthermore, the SRV-WG will explore the development of novel strategies for surveillance of TB drug resistance based on high-throughput molecular technologies.


4Q, 2015 Progress:

« » View all